Vinati Organics (524200) Q1 26/27 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 26/27 earnings summary
30 Sep, 2026Executive summary
Revenue grew by 28% year-over-year in Q1, driven by rupee depreciation, higher export volumes, and new products, with unaudited standalone and consolidated financial results approved and reviewed by the Board and auditors.
EBITDA increased by 7% year-over-year, with margin compression due to higher raw material costs and limited pass-through.
Net profit rose by 4.5% year-over-year, reflecting margin pressure, with both standalone and consolidated results showing continued operations in chemical manufacturing.
Financial highlights
Standalone revenue from operations for Q1 FY27 was ₹697.75 crore, up from ₹542.26 crore in Q1 FY26; consolidated revenue was ₹695.91 crore, up from ₹541.97 crore.
Standalone net profit for Q1 FY27 was ₹123.56 crore, compared to ₹112.78 crore in Q1 FY26; consolidated net profit was ₹108.86 crore, compared to ₹104.19 crore.
EBITDA margin for the quarter was around 26%, in line with guidance.
55% of revenue came from exports, benefiting from currency movements.
Outlook and guidance
Confident in maintaining 26%-27% EBITDA margin for FY 2027, supported by product mix and capacity expansion.
Second half expected to outperform first half due to new product launches and capacity ramp-up.
Overall revenue growth of at least 15% projected for the year, with corresponding EBITDA growth.
Veeral Organics expected to contribute about INR 150 crores in FY 2028, with steady-state potential of INR 400-500 crores.
Latest events from Vinati Organics
- Strong revenue and profit growth reported for Q1 FY25, with robust performance in chemicals manufacturing.524200
Q1 24/25 - Strong year-over-year growth in revenue and profit, with robust cash flow and equity position.524200
Q2 24/25 - Q3 and nine-month results show strong growth and US expansion plans approved.524200
Q3 24/25 - FY25 saw robust profit growth, a Rs.7.50 dividend, and expansion with a new US subsidiary.524200
Q4 24/25 - Q1 margin rose to 30% on lower costs; year-over-year profit and revenue growth with strong outlook.524200
Q1 25/26 - Margins expanded and profits rose, supported by capacity growth and a CFO transition.524200
Q2 25/26 - Q3 FY26 delivered higher revenues and profits year-over-year, with robust financial health.524200
Q3 25/26 - Strong Q4 growth, robust audited results, and double-digit volume growth targeted for FY 2027.524200
Q4 25/26